Financing channel feed – Endpoints News

Financing channel feed

WuXi AppTec files for public listing in Hong Kong four months after explosive Shanghai IPO

7 years ago

Launch a new company, steer a $150M IPO and ink a big data collaboration — they call it Monday at Vivek Ramaswamy’s Roivant

7 years ago

After a 6-month romp, Arie Belldegrun and David Chang fly a $100M-plus IPO for off-the-shelf CAR-T player Allogene

7 years ago

Upsized and top-of-the-range: Fall round of biotech IPOs starts with a solid hit for Principia

7 years ago

Scouting early-stage oncology plays, biopharma vets Detlev Biniszkiewicz, Scott Chappel make VC debut at MPM

7 years ago

Vivo Capital bags $635M for its new biotech public company fund

7 years ago

Mike Narachi gets a $19M shot at a new approach to gene therapy — and he has another big market in mind

7 years ago

Atreca banks a $125M mega-round as it builds a pipeline of antibodies for cancer and ponders IPO timing

7 years ago

Focusing on the tumor microenvironment, OncoResponse garners $40 million for the next stage of the R&D journey

7 years ago

Chinese pharma powerhouse Hansoh joins fledgling biotechs in the Hong Kong IPO line

7 years ago

Circled by rival pharma giants and a biotech powerhouse, Kodiak asks for a $100M-plus IPO for new eye drug

7 years ago

MPM, Novartis lead a big launch round for Kazumi Shiosaki’s latest biotech startup coming out of Harvard

7 years ago

New investors pool $120M to bankroll Allogene's off-the-shelf CAR-T pipeline in drive to stay in the lead

7 years ago

Allied with Roche and AstraZeneca, 4D Molecular bags $90M round for its gene therapy pipeline work

7 years ago

PhaseBio raises $34M to test orphan disease strategy — focusing first on AstraZeneca drug

7 years ago

Eyeing an IPO, Fulcrum execs nail down an $80M round on the way to the clinic with their first gene-regulating drug

7 years ago

Partnering with Amgen vet Sean Harper, veteran VC Beth Seidenberg unveils a $320M fund and a unique focus on…wait for it…LA

7 years ago

Oxford spinout Evox grabs a $45M bankroll to advance to the clinic with new exosome tech

7 years ago

Illustrious Cambridge scientists join forces with $129M fund to bet on long plays in biotech

7 years ago

Qiming, Hillhouse bet on Jacobio's nascent pipeline of first-in-class drug hopefuls in $55M round

7 years ago

Allied with Genentech and Pfizer on discovery deals, protein degradation crew at Arvinas looks for $100M IPO ahead of PhI start

7 years ago

Closely allied with (both) Mercks and Celgene, Sutro CEO Bill Newell is laying out all his cards in a new IPO

7 years ago

As the maiden biotech IPO on the HKEX fizzles, some investment experts see an upside in tempering the hype

7 years ago

GSK spinout KaNDy raises $32M to fund a breakthrough shot at a women's health drug

7 years ago

First page Previous page 123 124 125126127 128 129 Next page Last page